MadeMed review: what the site discloses, and what the registries say back

MadeMed is the trading name of IDL Health LLC. The terms are plain about the structure: MadeMed runs the site, professional medical services come from MDI Medical Group PC and its affiliated physicians and providers, and prescriptions are filled by partner pharmacies, which the terms name as Absolute RX, Strive Pharmacy, ERX Hub and Southend Pharmacy. No street address for the company appears anywhere on the site, in the terms or the footer; there is an email address and a phone number.

This three-part split — platform, medical group, pharmacy — is the standard shape of the category, and MadeMed states it in the terms rather than leaving it to be inferred.

The menu is now 24 treatments across weight loss, longevity, sexual health, hormone health and hair. The ones this review covers are the peptides and the GLP-1s: injectable sermorelin, NAD+ as an injection or a nasal spray, glutathione, GHK-Cu for the scalp and the face, compounded semaglutide, compounded tirzepatide as an injection or a sublingual tablet, and the Mood Drive troche. Everything is sold on subscription.

The domain is older than the business, and the gap is large enough to matter when you are judging a seller by how long it has been around. The first capture in the Internet Archive, from December 2021, is a redirect to a page offering the domain for sale. The archive holds almost nothing until July 2025, and that capture shows a site selling oral GLP-1 for weight loss and nothing else. Everything reviewed here arrived after that.

The site was rebuilt in October 2026, and the terms were updated on 9 October. Every product moved to a new address; the old product pages, the credentials page and the pharmacy page now answer "not found".

What went:

• The named physician. In September a credentials page named a medical director and printed licence numbers. No physician is named anywhere on the site now; the about page says only that every consultation "is reviewed by a board-certified physician licensed in your state."
• The medical group and the pharmacies. The terms named Xpedicare, LLC as the medical group and AbsoluteRx as the pharmacy; the about page named Red Rock Pharmacy; a pharmacy page named AbsoluteRx and LinkRx with street addresses. All of that is replaced by the one list of four, without addresses.
• The six-month plan. Products were sold on three- and six-month terms. Every product now has 30-, 90- and 360-day terms.
• Oral sermorelin and oral semaglutide are off the menu. Glutathione, two GHK-Cu products and the sublingual tirzepatide are new.

What stayed: the entity, the subscription and cancellation terms, the absence of any first-month rate, the LegitScript badge, and the troche page's claim about PT-141 (section 08).

Every price on the site is a recurring plan rate on one of three terms, and the longest term is the cheapest month. Read on 25 October 2026 from the product pages, with the totals as the plan tables state them:

The monthly equivalents in brackets are the plan totals divided by three or by twelve. The weight-loss pages state that every dose is included in the price, and the 90-day plan ships as three shipments per charge.

Two things are absent that are usually present in this market, and both count in MadeMed's favour. There is no introductory rate anywhere on the site. And on most products the strength is printed beside the figure, so the comparison you make is a comparison of something.

The exception is the product most people come here for. In September the sermorelin page printed 9mg/3mL, a 30-day supply. On 25 October it names the active ingredient and prints no strength or vial size at all. A monthly price without a dose is not comparable to anything; until the page prints it again, ask before you pay.

The plan tables also list a consultation fee of $20, or $30 for a video visit. If no prescription is written, the product pages say the medication charge is refunded in full and the consultation fee is not; the returns policy adds that all sales of prescription and over-the-counter products are final.

The headline "from" figure on each page is the 360-day rate. The $143 sermorelin is a single charge of $1,718. Ninety days costs $161 a month, paid as $483. Month to month is $179. That is a different shape of catch from a first-month discount and, on balance, an honester one: you can see exactly what you are committing to before you commit. But the lowest monthly number is always the largest single payment, and that inversion catches people out.

The subscription policy says you are "charged on a recurring basis (e.g., every 30 or 90 days) until you cancel," that you may cancel at any time by email or through the portal, that "cancellations will be effective at the end of the current billing period," and that "we do not offer prorated refunds." Cancelling is easy and honestly described. On a 90- or 360-day plan, the period you are cancelling out of is already paid, and nothing comes back.

The blood test each injectable peptide requires is also outside every figure. Sermorelin needs an IGF-1 result and the NAD+ products a comprehensive metabolic panel; the pages tell you to go to any Labcorp or Quest location or upload results from the last six months, and price neither.

The terms name MDI Medical Group PC and "its affiliated physicians and providers." The site names no physician. We cannot verify a licence the site does not identify, so on 25 October there is nothing on the prescriber side to check against a board.

That is a step back from September, and it is worth being precise about what the step was. The old credentials page named a medical director and printed licence numbers. We checked two against the boards themselves — the Medical Board of California and the Vermont Board of Medical Practice — and both were current.

What failed then was the page's own "Verification Link" beside each licence, which pointed back at the page itself rather than at any board. The fix we asked for was to point those links at the boards. The page was removed instead, together with the physician, and the medical group named in the terms changed.

The terms and the about page give the same list: Absolute RX, Strive Pharmacy, ERX Hub and Southend Pharmacy, "strictly adhering to USP monographs", under the heading "State-Licensed 503A Cleanrooms". Nothing says which pharmacy fills which product, and none of the four comes with an address or the name its licence is held under.

Naming pharmacies is more than most of this market does. But a brand name is not a lookup key: to check a pharmacy against a state board you need the licensed entity and usually the address, and the page that gave addresses is gone. What we could match:

• Absolute RX. In September MadeMed's pharmacy page gave the Lutz, Florida address of Absolute Pharmacy, LLC, and PeterMD's terms name the same pharmacy at the same address. Florida permit PH28122 reads Clear on 26 October 2026: community pharmacy with Schedule II and III, issued 7 May 2014, current to 28 February 2027, no discipline on file, no public complaint. The FDA issued the same company a referral letter to the Florida Board of Pharmacy on 15 February 2017. That MadeMed's "Absolute RX" is this pharmacy is our match by name and by the address it used to publish, not something the site now states.
• Strive Pharmacy is a multi-state 503A chain operating through several licensed entities. Without knowing which state's Strive fills a MadeMed order, there is no single licence to look up.
• ERX Hub and Southend Pharmacy we could not tie to a licence from what the site publishes.

We found no FDA warning letter under MadeMed, IDL Health or any of the four pharmacy names.

The pharmacy the site named in September is no longer named. On 31 July 2026 the FDA had issued a Form 483 — nine inspectional observations, most about aseptic practice on semaglutide and tirzepatide lots — to CD Pharmacy, LLC dba Red Rock Pharmacy, which MadeMed's about page then called a partner.

A 483 is an investigator's list of observations, not a finding of violation. It no longer bears on what MadeMed sells today, unless one of the four new names turns out to be supplied by the same firm, and nothing on the site lets a reader find out.

Every page carries a LegitScript badge, and the about page carries the heading "Audited & Certified by LegitScript" with a link to verify. On 26 October 2026, after the rebuild, LegitScript's own certification lookup returned mademed.com as Certified, website type Pharmacy, secondary type Telemedicine, the same result as on 14 September.

The Mood Drive page sells a sublingual troche combining tadalafil, PT-141 and oxytocin, and says it "adds PT-141 (FDA-approved for low sexual desire)."

Bremelanotide — PT-141 — is approved, as Vyleesi, as a subcutaneous autoinjector for premenopausal women with hypoactive sexual desire disorder. The product on sale here is a compounded sublingual troche, and it is approved for nothing. A compounded preparation of an approved molecule does not inherit the approval; that is the distinction the whole compounding framework rests on.

One thing has improved since September: the page now prints all three doses — tadalafil 20 mg, PT-141 1 mg, oxytocin 20 IU — where it used to quantify only the tadalafil.

The answer to "is it available where I live" is now on the product pages only, and not on all of them. Sermorelin and the troche say they are offered in 40 states and name the ten they do not serve: Alabama, Alaska, Arkansas, Hawaii, Massachusetts, Missouri, New Mexico, New York, South Carolina and Virginia. The NAD+, glutathione and GHK-Cu pages publish no list.

In September the about page answered with a list of 40 while the NAD+ and injectable semaglutide pages listed 23, with Missouri, New Mexico and New York on opposite sides. The about page no longer answers the question at all. Check the page for the product you want, and if it gives no list, ask.

There is no Trustpilot profile for this company. We searched by domain and by operating entity on 1 September 2026 and found nothing filed. There is no BBB profile either, checked 14 October 2026. The rating widgets that used to sit on the product pages — 0.0 out of 5 on sermorelin, 4.2 on the troche in September — went with the rebuild.

What does exist is a press release issued through a paid newswire on 25 May 2026, headlined as a MadeMed review and labelled on its face as sponsored content containing affiliate links. It is the company's own marketing, and its prices no longer match the site.

None of this is disqualifying. A company that began selling peptides last year has not had time to accumulate a review record. It does mean there is no independent consumer signal to weigh against the company's own account of itself.

It may suit you if you want the strength on the label. NAD+ at 200 mg/mL, the nasal spray at 300 mg/mL, glutathione at 200 mg/mL, the GHK-Cu products at 3% — beside the price, on the product page.

If you have been burned by an introductory rate. There is no first-month price on this site to be burned by.

If you want lab-guided prescribing rather than a flat protocol. The injectable peptides require a blood result before a prescription is written.

It may not suit you if you want sermorelin and need to know the dose before you pay. The page no longer prints one.

If you want the lowest rate without prepaying. The headline figures are 360-day rates; $143 sermorelin is $1,718 up front, and cancelling mid-term returns nothing.

If you want the lab cost included. The injectables require a test the site tells you to arrange and pay for yourself.

If you want to know who prescribes and which pharmacy makes your medication. No physician is named, and the four pharmacies come without addresses or licensed names.

If you weigh an independent review record. There is none to weigh.

In September MadeMed disclosed more than most of the companies we track, and its disclosures survived checking better than we expected — with a consistent flaw: each one stopped a step short of the thing that would confirm it. The verification links did not reach the boards; the pharmacy names were not the licensed names.

The October rebuild resolved that flaw mostly by removing what could be checked. The physician and his licence numbers are gone rather than linked to the boards. The pharmacy addresses are gone rather than joined by licence names. The prices are clearer than before — three terms, the same on every product, no teaser — and the strengths are still printed on most products. But a reader can now check less about who prescribes and who compounds than in September.

Two things we would want changed. Name the prescribing physicians, or at least the medical group's state registrations, with links to the boards. And name each pharmacy by the entity that holds its licence, with the state, so a patient can look it up before ordering. Separately, the PT-141 line should come down.

Whether this is a good place to buy is a different question from whether the page is accurate, and we do not answer the first one. What we can say is what the site says, what we were able to check, and what we no longer can.

From MadeMed’s public pages, read Oct 25, 2026.

The terms and the about page name the same four partner pharmacies, with no addresses and nothing to say which fills which prescription. Until the October 2026 rebuild a separate pharmacy page gave addresses and named LinkRx, and the about page named Red Rock Pharmacy; that page is gone and neither name appears now. The terms name MDI Medical Group PC and its affiliated physicians; no physician is named anywhere on the site. Until the rebuild a credentials page named a medical director and the terms named Xpedicare, LLC.

Read from: MadeMed terms, MadeMed About.

How the other providers we cover answer the same question: which telehealth providers name their pharmacy.

How we reviewed this. Pricing, product descriptions, state lists and policy wording were read from MadeMed's own public pages on 25 October 2026 (the NAD+ nasal spray, glutathione and GHK-Cu scalp pages on 23 October) — the product pages listed above, about, terms and returns. The pages as they stood on 14 September 2026, before the rebuild, are described from our reading on that date.

Prescribers: the site names none; in September we verified the then-named medical director against the Medical Board of California and the Vermont Board of Medical Practice. Pharmacies: Absolute Pharmacy, LLC was checked against the Florida Department of Health MQA licence verification service on 26 October 2026; the other three could not be tied to a licence from what the site publishes.

FDA records were searched by company name for warning letters, with none found for MadeMed, IDL Health or the four pharmacy names. LegitScript certification was confirmed through LegitScript's lookup on 14 September and again on 26 October 2026. Third-party review platforms: no Trustpilot profile (searched 1 September 2026), no BBB profile (14 October 2026).

Editorial independence. PeptideWellness does not accept payment from telehealth providers, compounding pharmacies, or manufacturers in exchange for coverage, placement, or scoring. We have no commercial relationship with MadeMed.

Editorial note: This page is for informational purposes and doesn't constitute medical advice. Compounded medications aren't FDA-approved, aren't available in every state, and are prepared by a pharmacy rather than a manufacturer. Prices and licence records change; each figure above carries the date we read it. Last reviewed by Ksenia Petrushkina, PA-C, MPAS, October 2026.